Actuate Therapeutics, Inc. Liquidation Value
ACTU
Other
Cash & Equivalents
$13.16M
As of 2025-12-31
Current Price: $2.53 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $13.16M
Total Obligations: -$5.71M
$7.45M
Per share: $0.32
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $13.16M
AR: $0
Total Obligations: -$5.71M
$7.45M
Per share: $0.32
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $13.16M
AR: $0
Inventory: $0
Total Obligations: -$5.71M
$7.45M
Per share: $0.32
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $7.45M | $0.32 |
| Liquid Liquidation Value | $7.45M | $0.32 |
| Operating Liquidation Value | $7.45M | $0.32 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $13.16M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $5.71M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 23.2M |
Explore all 120 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $13.16M | N/A | N/A | $1.52M | $5.71M | N/A | N/A | N/A |
| 2025-09-30 | $16.92M | N/A | N/A | $1.25M | $6.37M | N/A | N/A | N/A |
| 2025-06-30 | $6.49M | N/A | N/A | $3.17M | $9.20M | N/A | N/A | N/A |
| 2025-03-31 | $3.89M | N/A | N/A | $2.64M | $9.15M | N/A | N/A | N/A |
| 2024-12-31 | $8.64M | N/A | N/A | $1.92M | $8.80M | N/A | N/A | N/A |
| 2024-09-30 | $13.52M | N/A | N/A | $2.33M | $8.50M | N/A | N/A | N/A |
| 2024-06-30 | $351,709 | N/A | N/A | $5.89M | $20.07M | N/A | N/A | N/A |
| 2024-03-31 | $2.07M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes